Last updated on: 04/02/2013
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: IMS Health
Name of data sourceIMS Lifelink Prescription Claims Data - Canada
Name under which the data source should be displayed in the inventory (e.g short name if one exists)Prescription Claims Data - Canada
Name of organisation
1) Department/research groupReal World Evidence Solutions
2) Organisation/affiliationIMS Health
Administrative Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
Scientific Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
2. Description/category
Prescription event monitoring
Administrative database, e.g. claims database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Community / general practice data
3.2 ATC code (5th level)
No
3.3 Other product dictionaries
DIN code available in Canada
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
5. Year of establishment
1994
6. Geographical origin of data
Non EEA/EFTA areas
North America
7. Demographical extent of data collection
Nation-wide
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
adolescents (12 to 17 years)
18 to 45 years
46 to 64 years
65 years and over
65 to 75 years
76 years and over
9. Size of the source/catchment population
14,000,000
10 a. Total (cumulative) number of persons with actual data
10 b. Number of persons with active data collection in past calendar year
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
No
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
No
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
No
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
1. COMPUS. Current Utilization of Blood Glucose Test Strips in Canada. Optimal Therapy Report. 2009 Mar; 3(2):1-28.
2. Williams RE, Bosnic N, Sweeney CT, Duncan AW, Levine KB, Brogan M, Cook SF. Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec. Pain Res Manag. 2008 Sep-Oct;13(5):395-400.
3. Khoo K, Colucci R, Hryniuk W, Kamino R, Redina T, Savage C. The cost of cancer drugs in Canada. Report Card On Cancer In Canada. 2007:53-59.
4. Khoo K, Colucci R, Hryniuk W, Kamino R, Redina T, Savage C. The cost of cancer drugs in Canada, Part 2: Who Is bearing the cost? Report Card On Cancer In Canada. 2008:23-32.
5. Wakim R. Cost of effectiveness. Benefits of Canada. 2009 June 01.
